FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Aurobindo Pharma Dextroamphetamine Sacharate Recall

Dextroamphetamine Sacharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphe…

Aurobindo Pharma USA Inc. · East Windsor, NJ

Risk level
Class II
Reported by FDA
Oct 23, 2019
Recall ID
D-0143-2020
Check your lot numberHow we source this data

Summary

Aurobindo Pharma recalled Dextroamphetamine Sacharate starting Sep 19, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0143-2020 on Oct 23, 2019. Reason: Superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thickness. Status: Terminated.

Why it was recalled

Superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thickness.

Product description

Dextroamphetamine Sacharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Mixed Salts of a single Entity Amphetamine Product), 20mg, 100-count bottle, RX Only, Distributed by: Aurobindo Pharma USA Inc., Dayton, NJ 08810, NDC 13107-073-01

Lot numbers, UPCs & expiration codes

Batch 07319032A1, Exp 02/2021

Where it was sold

Nationwide in the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0143-2020
Classification
Class II
Status
Terminated
Recall initiated
Sep 19, 2019
FDA report date
Oct 23, 2019
Quantity
11,129 100-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Aurobindo Pharma USA Inc.

Original FDA data

Every field from FDA enforcement report D-0143-2020, exactly as published.

Show all FDA fields
City
East Windsor
State
NJ
Status
Terminated
Country
United States
Event ID
83848
Address
279 Princeton Hightstown Rd
Code information
Batch 07319032A1, Exp 02/2021
Postal code
08520-1401
Report date
Oct 23, 2019
Product type
Drugs
Recall number
D-0143-2020
Classification
Class II
Recalling firm
Aurobindo Pharma USA Inc.
Product quantity
11,129 100-count bottles
Termination date
Apr 4, 2023
Reason for recall
Superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thickness.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Dextroamphetamine Sacharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Mixed Salts of a single Entity Amphetamine Product), 20mg, 100-count bottle, RX Only, Distributed by: Aurobindo Pharma USA Inc., Dayton, NJ 08810, NDC 13107-073-01
Distribution pattern
Nationwide in the US
Recall initiation date
Sep 19, 2019
Initial firm notification
Letter
Center classification date
Oct 15, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0143-2020, published Oct 23, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls